Programmed Cell Death 1 Ligand 2 Protéines
(Programmed Cell Death 1 Ligand 2 (PDCD1LG2))
Involved in the costimulatory signal, essential for T- cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production (By similarity).
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| PDCD1LG2 Protein (AA 20-220) (His tag) | Humain | Bacteria |
|
302,50 €
Voir le prix
|
|
| PDCD1LG2 Protein (partial) (His tag) | Souris | HEK-293 Cells |
|
757,63 €
Voir le prix
|
|
| PDCD1LG2 Protein (partial) (Fc Tag) | Souris | HEK-293 Cells |
|
757,63 €
Voir le prix
|
|
| PDCD1LG2 Protein (partial) (Fc Tag) | Humain | HEK-293 Cells |
|
757,63 €
Voir le prix
|
|
| PDCD1LG2 Protein (His tag) | Humain | Escherichia coli (E. coli) |
|
503,00 €
Voir le prix
|
|
| PDCD1LG2 Protein (His tag) | Humain | Mammalian Cells |
|
730,00 €
Voir le prix
|
|
| PDCD1LG2 Protein (His tag) | Humain | Human Cells |
|
878,90 €
Voir le prix
|
|
| PDCD1LG2 Protein (Fc Tag) | Souris | Human Cells |
|
438,90 €
Voir le prix
|
Protein
- Origine
- Humain
- Hôte
- Bacteria
- Type Proteine
- Recombinant
Protein
- WB (Western Blotting: Application indiquée)
- Origine
- Souris
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- >95 % as determined by SDS-PAGE.
Protein
- WB (Western Blotting: Application indiquée)
- Origine
- Souris
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- >95 % as determined by SDS-PAGE.
Protein
- WB (Western Blotting: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Origine
- Humain
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- >95 % as determined by reduced SDS-PAGE.
- Activité biologique
- Active
Protein
- WB (Western Blotting: Application indiquée)
- SDS (SDS-PAGE: Application indiquée)
- Imm (Immunogen: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Origine
- Humain
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
Protein
- WB (Western Blotting: Application indiquée)
- SDS (SDS-PAGE: Application indiquée)
- Imm (Immunogen: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Origine
- Humain
- Hôte
- Mammalian Cells
- Type Proteine
- Recombinant
Protein
- Origine
- Humain
- Hôte
- Human Cells
- Type Proteine
- Recombinant
- Pureté
- Greater than 95 % as determined by reducing SDS-PAGE.
Protein
- Origine
- Souris
- Hôte
- Human Cells
- Type Proteine
- Recombinant
- Pureté
- Greater than 95 % as determined by reducing SDS-PAGE.
Dernières publications pour nos Programmed Cell Death 1 Ligand 2 Protéines
: "Programmed death ligand 2 - A link between inflammation and bone loss in rheumatoid arthritis." dans: Journal of translational autoimmunity, Vol. 3, pp. 100028, (2020) (PubMed).
: "In Vitro Assays to Study PD-1 Biology in Human T Cells." dans: Current protocols in immunology, Vol. 130, Issue 1, pp. e103, (2020) (PubMed).
: "Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functions." dans: The Journal of biological chemistry, Vol. 295, Issue 52, pp. 18036-18050, (2020) (PubMed).
: "PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways." dans: Immunity, Vol. 51, Issue 6, pp. 1059-1073.e9, (2019) (PubMed).
: "Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy." dans: Journal for immunotherapy of cancer, Vol. 6, Issue 1, pp. 149, (2018) (PubMed).
: "In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy." dans: Science translational medicine, Vol. 9, Issue 389, (2018) (PubMed).
: "In Vitro Assays to Study PD-1 Biology in Human T Cells." dans: Current protocols in immunology, Vol. 130, Issue 1, pp. e103, (2020) (PubMed).
: "Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functions." dans: The Journal of biological chemistry, Vol. 295, Issue 52, pp. 18036-18050, (2020) (PubMed).
: "PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways." dans: Immunity, Vol. 51, Issue 6, pp. 1059-1073.e9, (2019) (PubMed).
: "Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy." dans: Journal for immunotherapy of cancer, Vol. 6, Issue 1, pp. 149, (2018) (PubMed).
: "In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy." dans: Science translational medicine, Vol. 9, Issue 389, (2018) (PubMed).
Pseudonymes pour Programmed Cell Death 1 Ligand 2 Protéines
programmed cell death 1 ligand 2 (PDCD1LG2) Protéinesprogrammed cell death 1 ligand 2 (Pdcd1lg2) Protéines
B7-DC Protéines
B7DC Protéines
bA574F11.2 Protéines
Btdc Protéines
CD273 Protéines
F730015O22Rik Protéines
PD-L2 Protéines
PDCD1L2 Protéines
PDL2 Protéines
Avez-vous cherché autre chose?
- Programmed Cell Death 1 Protéines
- Progesterone Receptor Protéines
- Profilin 4 Protéines
- Profilin 3 Protéines
- Profilin Protéines
- PRODH2 Protéines
- PRODH Protéines
- PROCR Protéines
- Procathepsin K Protéines
- Procalcitonin Protéines
- PROCA1 Protéines
- PROC Protéines
- Pro-Platelet Basic Protein (Chemokine (C-X-C Motif) Ligand 7) Protéines
- PRO-ANP Protéines
- PRNP Protéines
- PRND Protéines
- PRMT8 Protéines
- PRMT7 Protéines
- PRMT6 Protéines
- PRMT5 Protéines
- Programmed Cell Death 10 Protéines
- Programmed Cell Death 4 Protéines
- Prohibitin Protéines
- Prohibitin 2 Protéines
- PROK2 Protéines
- Prokineticin 1 Protéines
- Prokineticin Receptor 1 Protéines
- Prokineticin Receptor 2 Protéines
- PROL1 Protéines
- Prolactin Protéines
- Prolactin Family 2, Subfamily A, Member 1 Protéines
- Prolactin Family8, Subfamily A, Member 9 Protéines
- Prolactin Receptor Protéines
- Proliferating Cell Nuclear Antigen Protéines
- Proline Rich 13 Protéines
- Proline Rich 15 Protéines
- Proline Rich 15-Like Protéines
- Prominin 2 Protéines
- PROP1 Protéines
- Propionyl CoA Carboxylase, alpha Polypeptide Protéines
Vous êtes ici:
